Fundraising September 15, 2024 – October 1, 2024 About fundraising

Nivolumab plus ipilimumab or nivolumab alone versus...

  • Main
  • 2018 / 10
  • Nivolumab plus ipilimumab or nivolumab alone versus...

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

Hodi, Frank Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Cowey, Charles Lance, Lao, Christopher D, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferruc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30700-9
Date:
October, 2018
File:
PDF, 1.31 MB
english, 2018
Conversion to is in progress
Conversion to is failed